3294 studies found for:    Open Studies | "Endocrine System Diseases"
Show Display Options
Rank Status Study
21 Recruiting Tissue Samples and Bodily Fluid Specimens Banking
Condition: Endocrine Disorders of Female Reproductive System
Intervention: Procedure: collect body fluids/tissues & med history
22 Recruiting Preservation of Ovarian Tissue and Chemo-Radiotherapy
Conditions: Endocrine Disorders of Female Reproductive System;   Secondary Infertility;   Infertility Involuntary
Intervention: Procedure: surgery
23 Recruiting Characteristics of Women With Reproductive Concerns
Condition: Endocrine Disorders of Female Reproductive System
Intervention:
24 Recruiting Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Children
Conditions: Autoimmune Disease;   Congenital Adrenal Hyperplasia;   Healthy;   Mental Disorder Diagnosed in Childhood;   Neurologic Manifestations
Intervention:
25 Unknown  Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans
Conditions: Type 2 Diabetes Mellitus;   Insulin Resistance
Intervention: Drug: Resveratrol
26 Recruiting Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting
Condition: Diabetes Mellitus, Type 1
Interventions: Device: CGM and Insulin Pump;   Device: Closed-Loop Control System
27 Recruiting A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Device: PaQ® Insulin Delivery Device;   Drug: Insulin, Asp(B28)-
28 Not yet recruiting Clomiphene Citrate for the Treatment of Obesity Related Male Hypogonadism
Conditions: Obesity;   Hypoandrogenism
Interventions: Drug: Clomiphene Citrate;   Drug: Placebo
29 Recruiting RTA 402 Phase 2 Clinical Trial (A Randomized, Double-blind, Placebo-controlled Clinical Trial in Patients With Chronic Kidney Disease and Type 2 Diabetes)
Conditions: Chronic Kidney Disease;   Type 2 Diabetes
Interventions: Drug: RTA 402;   Drug: Placebo
30 Recruiting Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia
Conditions: Type 1 Diabetes Mellitus;   Nocturnal Hypoglycemia;   Recurrent Severe Hypoglycaemia
Interventions: Drug: Insulin aspart/glargine;   Drug: Insulin aspart/degludec
31 Recruiting Accuracy of Two CGM Systems Tested Simultaneously in Ambulatory Patients With Type 1 Diabetes
Conditions: Diabetes Mellitus, Type 1;   Blood Glucose
Interventions: Device: Guardian Enlite sensor;   Device: Dexcom G4 platinum sensor
32 Recruiting A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus
Interventions: Drug: HM11260C;   Drug: Placebo;   Drug: Victoza
33 Recruiting Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca
Condition: Stage IV Pancreatic Cancer
Intervention: Drug: Ascorbic Acid
34 Unknown  Effects of Alogliptin on Pancreatic Beta Cell Function
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Alogliptin;   Drug: Metformin 750 mg
35 Recruiting Trial Comparing Metabolic Efficiency of Islet Graft to Intensive Insulin Therapy for Type 1 Diabetes's Treatment
Condition: Diabetes Mellitus, Type 1
Intervention: Procedure: human pancreatic islet transplantation
36 Recruiting Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Saxagliptin 5 mg;   Drug: Placebo 5 mg for Saxagliptin;   Drug: Placebo 500 mg for metformin (with titration);   Drug: Metformin 500 mg with titration
37 Recruiting Versartis International Trial in Adults With Long-Acting Growth Hormone
Condition: Adult Growth Hormone Deficiency
Intervention: Drug: VRS-317
38 Recruiting Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (VRS-317)
Conditions: Pediatric Growth Hormone Deficiency;   Growth Disorders
Intervention: Drug: VRS-317
39 Recruiting Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
Condition: Growth Hormone Deficiency
Interventions: Drug: TV-1106;   Drug: dGH
40 Recruiting A Trial to Compare the Safety of Once Weekly Dosing of NNC0195-0092 With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency
Conditions: Adult Growth Hormone Deficiency;   Growth Hormone Disorder
Interventions: Drug: NNC0195-0092;   Drug: somatropin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years